The World Health Organization estimates that over 270 million people worldwide are affected by SUDs, with annual cost exceeding $700 billion due to healthcare utilization, criminal justice involvement, and productivity losses (2)
Can years of GLP-1 receptor stimulation eventually cause the same C-cell problems seen in two-year rodent studies
FDA-approved branded medications include Wegovy and Ozempic (semaglutide) and Zepbound and Mounjaro (tirzepatide)
It works synergistically with GHRHs and lacks the lipogenic properties (fat creation/storage) of ghrelin
Supports blood sugar control: Good hydration helps blood flow and nutrient transport, which supports steady glucose handling while on these medications
Rather than a quick fix, these weight loss programs will be built for the long term, empowering customers to lose up to 20% of their body weight